Executive Series: Reva Medical (RVA) CEO, Regina Groves

CommSec

Online Stockbroker

Executive Series: Reva Medical (RVA) CEO, Regina Groves

In this short video we discuss:

RVA’s background as a medical device company and the development of proprietary technology that is being marketed as an alternative to metal stents, to treat coronary artery disease. These ‘scaffolds’ provide restoration of blood flow, support the artery through the healing process, then disappear or “resorb” from the body over a period of time.
The Company’s Fantom scaffold which has been designed to offer a balance of thinness and strength, with distinct ease-of-use features including visibility under x-ray, expansion with one continuous inflation, and no procedural time limitations.
RVA’s major milestones over the past year, including the launch of its Fantom product in Europe and the results of its clinical trial.

 

 


1 topic

1 stock mentioned

CommSec
Online Stockbroker
Online Stockbroker

CommSec is Australia's leading online broker. CommSec has been committed to providing the best in online trading since 1995. CommSec helps make informed investment decisions with comprehensive market research, free live pricing and powerful...

Expertise

No areas of expertise

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.